HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,011 Cr | ₹933 Cr | ₹662 Cr | ₹828 Cr | ₹703 Cr |
What is the latest Total Current Liabilities ratio of HIKAL ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,011 Cr |
| Mar2024 | ₹933 Cr |
| Mar2023 | ₹662 Cr |
| Mar2022 | ₹828 Cr |
| Mar2021 | ₹703 Cr |
How is Total Current Liabilities of HIKAL Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,011 Cr | 8.36 | |
| Mar2024 | ₹933 Cr | 41.00 | |
| Mar2023 | ₹662 Cr | -20.12 | |
| Mar2022 | ₹828 Cr | 17.75 | |
| Mar2021 | ₹703 Cr | - | |
Compare Total Current Liabilities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,569.6 Cr | -1.2% | 13.8% | -47.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,032.0 Cr | 0.9% | 12.8% | 4.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹183,759.0 Cr | 3.2% | 14% | 13.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,224.0 Cr | 0.7% | 5.5% | 36.9% | Stock Analytics | |
| CIPLA | ₹116,214.0 Cr | 6.8% | 18.8% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,739.0 Cr | 0.7% | 5.5% | 9.4% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -1.2% |
13.8% |
-47.8% |
| SENSEX | -3.1% |
-2.8% |
-6.1% |
You may also like the below Video Courses